Penanganan Kasus Kehamilan 32 Minggu dengan Hipertiroid Janin-Fetal Goiter

Anggy Albernande, Muhammad Al Farisi Sutrisno, Peby Maulina Lestari, Rose Mafiana, Yulianto Kusnadi, Indrayadi Indrayadi, Aditiawati Aditiawati


Hipertiroid pada kehamilan didefinisikan sebagai peningkatan kadar free T4. Hipertiroid terjadi pada 2/1000 kehamilan yaitu hipertiroid yang tidak terkontrol selama kehamilan meningkatkan risiko krisis tiroid, kelahiran prematur, dan kematian janin. Pasien Ny. DK 21 tahun datang dengan keluhan benjolan di leher kanan sebesar telur puyuh, hamil 21 minggu, dengan hasil USG fetal goiter. Pemeriksaan fisik didapatkan keadaan umum baik, suhu 36,60C; tekanan darah: 120/80 mmHg; frek. nadi: 92x/menit; frek. nafas: 20 x/menit. Pada pemeriksaan Leopold I didapatkan tinggi fundus uteri 21 cm, teraba bagian lunak. Leopold II teraba tahanan memanjang di sisi kiri kesan punggung. Leopold III teraba bagian terbawah bulat, melenting dan keras U 5/5, kesan kepala. DJJ 159x/mnt, TBJ 1240 gram. Pada pasien dilakukan observasi dan kontrol dengan rentang 2 minggu setelah pemeriksaan. Tata laksana pada pasien ini adalah asam folat, kalsium karbonat, vitamin D, propylthiouracil, folamil, dan ferrous sulfat.

Management of Cases 32 Weeks Gestational Pregnancy with Fetal Hyperthyroidism-Fetal Goiter

Hyperthyroidism in pregnancy is defined as an increase in free T4 levels. Hyperthyroidism occurs in 2/1000 pregnancies where uncontrolled hyperthyroidism during pregnancy increases the risk of thyroid crisis, premature birth and fetal death. Patient Mrs. 21 year old DK came with complaints of a lump in her right neck the size of a quail egg, 21 weeks pregnant, with ultrasound results of fetal goiter. Physical examination revealed good general condition, temperature 36.60C; blood pressure: 120/80 mmHg; Strange. pulse: 92x/minute; Strange. breath: 20 x/minute. On examination by Leopold I, the height of the uterine fundus was 21 cm, and the soft part was palpable. Leopold II has a longitudinal resistance on the left side of the dorsal impression. Leopold III palpable lower part round, melted and hard U 5/5, head impression. DJJ 159x/minute, TBJ 1240 grams. Patients were observed and monitored at intervals of 2 weeks after the examination. Treatment for this patient is folic acid, calcium carbonate, vitamin D, propylthiouracil, folamyl and ferrous sulfate.

Key words: Hyperthyroidism, fetal goiter, propylthiouracil


Hipertiroid, fetal goiter, propylthiouracil

Full Text:



Norton ME, Scoutt LM, Feldstein VA. Callen’S Ultrasonography in Obstetrics and Gynecology, Sixth Edition [Internet]. Vol. 53, Elsevier. 2017. 1275 p. Available from: file:///C:/Users/User/Downloads/fvm939e.pdf

Cunningham FG, Leveno KJ, Dashe JS, Hoffman BL, Spong CY, Casey BM.Williams Obstetrics [Internet]. New York, NY: McGraw Hill; 2022. Available from:

Andersen SL, Andersen S. Hyperthyroidism in pregnancy: evidence and hypothesis in fetal programming and development. Endocr Connect [Internet]. 2021 Feb;10(2):R77–86. Available from:

Morales DR, Fonkwen L, Nordeng HME. Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations. Br J Clin Pharmacol. 2021 Oct;87(10):3890–900.

Nguyen CT, Sasso EB, Barton L, Mestman JH. Graves’ hyperthyroidism in pregnancy: a clinical review. Clin Diabetes Endocrinol. 2018;4(1):1–9.

Suparman E. Hipertiroid dalam Kehamilan. e-CliniC. 2021;9(2):479.

Aggarawal N, Suri V, Singla R, Chopra S, Sikka P, Shah VN, et al. Pregnancy outcome in hyperthyroidism: A case control study. Gynecol Obstet Invest. 2014;77(2):94–9.

Akamizu T, Satoh T, Isozaki O, Suzuki A, Wakino S, Iburi T, et al. Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid. 2012 Jul;22(7):661–79.

Bliddal S, Rasmussen AK, Sundberg K, Brocks V, Feldt-Rasmussen U. Antithyroid drug-induced fetal goitrous hypothyroidism. Nat Rev Endocrinol. 2011 Mar;7(7):396–406.

Bargman JM, Skorecki KL. Harrison’s Principles of Internal Medicine 20th Ed. 2021. p. 1111–20.

De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet (London, England). 2016 Aug;388(10047):906–18.

Cooper DS, Laurberg P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol [Internet]. 2013;1(3):238–49. Available from: Ramprasad M, Bhattacharyya SS, Bhattacharyya A. Thyroid disorders in pregnancy. Indian J Endocrinol Metab [Internet]. 2012 Dec;16(Suppl 2):S167–70. Available from:

Ross SD. Hyperthyroidism during pregnancy treatment. uptodate. 2022;7(7):84.

Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994 Dec;84(6):946–9.

Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011 Oct;21(10):1081–125.

De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012 Aug;97(8):2543–65.

Corral E, Reascos M, Preiss Y, Rompel SM, Sepulveda W. Treatment of fetal goitrous hypothyroidism: value of direct intramuscular L-thyroxine therapy.Prenat Diagn [Internet]. 2010 Sep 1;30(9):899–901. Available from:

Iijima S. Current knowledge about the in utero and peripartum management of fetal goiter associated with maternal Graves’ disease. Eur J Obstet Gynecol Reprod Biol X [Internet]. 2019;3:100027. Available from:

Didier-Mathon H, Bouchghoul H, Senat MV, Young J, Luton D. Prenatal management of fetal goiter alternating between hypothyroidism and hyperthyroidism in a mother with Graves’ disease. Clin Case Reports. 2021;9(4):2281–4.

Nemescu D, Tanasa I, Stoian D, Navolan D, Vinturache A. Conservative in utero treatment of fetal dyshormonogenetic goiter with levothyroxine, a systematic literature review. Exp Ther Med. 2020;2434–8. Onteddoo JR. Prenatal diagnosis of intrauterine fetal fracture. A case report. J Dr NTR Univ Heal Sci. 2019;8(1):52–8.

Fujishima A, Sato A, Miura H, Shimoda Y, Kameyama S, Ariake C, et al. Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves’ disease: A case report. BMC Pregnancy Childbirth. 2020;20(1):1–6.

Stoppa-Vaucher S, Van Vliet G, Deladoey J. Discovery of a fetal goiter on prenatal ultrasound in women treated for Graves’ disease: first, do no harm. Thyroid [Internet]. 2011 Jan 28;21:931. Available from:

Allen RH, Cwiak CA. Contraception for the medically challenging patient. Contracept Medically Challenging Patient. 2014;1–375.

WHO. Medical eligibility criteria for contraceptive use. 5th ed. WHO; 2015.

Deswita F, Ps RD, Ilmu B, Kedokteran F, Lampung U. Thyroid Disease in Pregnancy : Diagnosis and Management. 2019;9:186–91.

Dadhich S, Agrawal S, Soni M, Choudhary R, Jain R, Sharma S, et al. Predictive value of platelet indices in development of preeclampsia. J SAFOG. 2012;4(1):17–21.

Okosieme OE, Khan I, Taylor PN. Preconception management of thyroid dysfunction. Clin Endocrinol (Oxf). 2018;89(3):269–79.

Lazarus JH. Pre-Conception Counselling in Graves’ Disease. Eur Thyroid J. 2012;1(1):24–9.



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


Creative Commons License
Indonesian Journal of Obstetrics & Gynecology Science is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
  Web Analytics
  View My Stat